探索治疗潜力:通过菌体平台传递反意义RNA
Amir Jalali1, Majid Komijani1, Hussein Alyafuri1
1Department of Biology, Faculty of Science, Arak University, Arak, 38156-8-8349, Iran.
Iranian journal of biotechnology
|October 20, 2025
概括
包括反感性寡核酸 (ASO) 在内的RNA疗法在遗传疾病方面表现有前途. 先进的传递系统,如菌体和病毒样颗粒,提高ASO的有效性,克服各种应用的挑战.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 治疗方法 治疗方法
背景情况:
- 核酸治疗药物,特别是反感性寡核酸 (ASO),在治疗遗传疾病方面取得了重大进展.
- 通过向特定的RNA分子,RNA医学提供了潜在的治疗干预措施,但在稳定性,输送和非目标效应方面面临挑战.
研究的目的:
- 审查RNA疗法的机制,应用和交付平台,重点关注反感性寡核酸.
- 探索创新的输送系统,以提高疗效,克服与基于RNA的疗法相关的挑战.
主要方法:
- 关于RNA疗法,反意义寡核酸和各种交付平台的现有文献的全面审查.
- 分析RNA疗法的机制,应用和临床影响,包括菌体和病毒样粒子系统.
- 对FDA批准的ASO药物和CRISPR衍生方法的检查.
主要成果:
- 各种传递平台,包括脂质纳米颗粒,聚合纳米颗粒,细胞透,外体,多重复和病毒样颗粒 (VLPs),用于改善RNA稳定性和细胞内传递.
- 菌体和VLP显示出显著的潜力,作为RNA疗法的多功能传递系统,准细菌感染,生物膜根除,癌症和病毒感染.
- 使用菌体进行有针对性的输送,可以提高治疗效果,因为它们易于开发,装载量大,安全.
结论:
- RNA疗法,特别是ASO,在治疗遗传疾病和其他疾病方面具有很大的前景.
- 先进的输送系统对于克服RNA疗法固有的挑战至关重要,提高其临床适用性.
- 探索菌体和VLP等新平台扩大了基于RNA的干预措施的治疗潜力,为疾病治疗提供了新的途径.
相关概念视频
DNA Bacteriophages
800
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
800
Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K


